RAP opportunity at National Institute of Standards and Technology NIST
Ensuring the Safety of Vaccines and Biologics
Location
Material Measurement Laboratory, Biomolecular Measurement Division
opportunity location
50.64.51.C0631 Gaithersburg, MD
NIST only participates in the February and August reviews.
Advisers
name email phone
Megan Hussey Cleveland megan.cleveland@nist.gov 301.975.5473
Description
Biologic products such as monoclonal antibodies (mAbs), viral vaccines and some gene therapies are produced using cell lines and may become contaminated with adventitious agents during the manufacturing process via cell banks, raw materials, or the environment. These adventitious agents can potentially cause harm to recipients. Current testing methods are very time consuming and may not detect all types of viral adventitious agents. Next-generation sequencing offers the potential for nontargeted detection and rapid turnaround time. The Applied Genetics Group is investigating potential standards and methods for NGS detection of viral adventitious agents. Applicants with experience in molecular biology, qPCR, digital PCR, cell culture, viral propagation, bioinformatics or next-generation sequencing are encouraged to apply.
key words
biologics; virus; molecular biology; NGS; cell culture
Eligibility
citizenship
Open to U.S. citizens
level
Open to Postdoctoral applicants
Stipend
Base Stipend Travel Allotment Supplementation
$82,764.00 $3,000.00
Similar Positions
-
Fda Research Opportunity In Developing Methods For Efficient Gene Editing In Hematopoietic Stem Cells (Hs Cs), Center for Biologics Evaluation and Research (CBER), United States, about 3 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately in the Division of Cell Therapy (DCT2), within the Office of Cellular Th...
-
Associate Research Scientist (Prep0004151), Johns Hopkins University, United States, 16 days ago
Details Posted: Unknown Location: Salary: Summary: Summary here. Details Posted: 20-Mar-26 Location: Gaithersburg, Maryland Type: Full-time Salary: 90,000.00 - 110,000.00 Categories: Academic/Facu...
-
Fda Computational And Experimental Assessment Of Engineered Biotherapeutics: Safety And Regulatory Considerations Of Synonymous Gene Recoding, Center for Biologics Evaluation and Research (CBER), United States, about 2 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available at the Office of Therapeutic Products (OTP), Center for Biologics Evaluati...
-
Fda Non Clinical Identification And Mitigation Of Safety Risks During The Development And Licensure Of Protein Therapeutics, Center for Biologics Evaluation and Research (CBER), United States, 6 days ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Division of Plasma Protein Therapeutics (DPPT), Center for Biologics Evaluati...
-
Fda Evaluation And Characterization Of Neutralizing Antibodies Against Viruses Relevant To Blood Derived Products, Center for Biologics Evaluation and Research (CBER), United States, about 2 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available with the Office of Therapeutics Proteins (OTP) at the Center for Biologics...
-
Usda Ars Efficient Detection And Management Of Phytoplasma And Spiroplasma Induced Plant Diseases In Forestry And Agriculture, Zintellect, United States, 14 days ago
Organization U.S. Department of Agriculture (USDA) Reference Code USDA-ARS-NEA-2026-0132 How to Apply To submit your application, scroll to the bottom of this opportunity and click APPLY. A comple...